Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYImmunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual MeetingPREV STORYTeladoc Announces U.S. Launch of Behavioral Health Navigator